Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
CompletedOBSERVATIONAL
Enrollment
23
Participants
Timeline
Start Date
July 31, 2011
Primary Completion Date
December 31, 2014
Study Completion Date
June 30, 2015
Conditions
Breast NeoplasmsNeoplasm Metastasis
Trial Locations (1)
100142
Beijing Cancer Hospital, Beijing
All Listed Sponsors
lead
Peking University Cancer Hospital & Institute
OTHER
NCT01395056 - Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients | Biotech Hunter | Biotech Hunter